We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04111666
Recruitment Status : Completed
First Posted : October 1, 2019
Last Update Posted : August 10, 2022
Information provided by (Responsible Party):
Alector Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 9, 2022
Actual Study Completion Date : June 9, 2022